Stock Split Watch: Lilly — Is Eli Lilly Next to Split?
Eli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
Indices offer a practical way to quantify risk exposure and monitor changes over time, supporting proactive adjustments.
27,018 articlesEli Lilly has been a standout growth stock thanks to GLP-1 drug demand. Could a stock split be on the horizon? This g...
A common retirement pitfall hinges on COBRA coverage not extending Medicare enrollment windows. This piece explains h...
April retail sales rose 0.5% to $757.1 billion, lifting cash flow for consumer staples stocks. The ETF’s yield remain...
Two leading midstream ETFs, AMLP and MLPX, battle for income and tax efficiency as the 2026 energy rally persists. Th...
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Palantir’s CEO has shifted away from traditional earnings calls, instead sending quarterly shareholder letters that m...
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
The Magnificent 7 erased $2.3 trillion in market value in June, signaling investors are reassessing AI bets and the t...
As volatility expectations shift in mid-2026, a changing VIX futures curve could compress SVOL’s monthly distribution...
Wolfe Research issues a split verdict on restaurant stocks, downgrading Starbucks while upgrading Brinker and initiat...
The market mood says AI spending is peaking. But one company’s long-term orders hint at a different story. This guide...